As the global in vitro diagnostics (IVD) industry undergoes rapid technological evolution and market restructuring, overseas expansion has become a key growth pathway for Chinese IVD companies. ..

Amid stronger policy support, rapid biomedical innovation, and rising public awareness of health management, healthcare system is accelerating a shift from reactive treatment to proactive, continuous care. ..

CACLP 2026 will debut the Medical Research Pavilion as a dedicated platform designed to bridge scientific research with clinical practice within the healthcare system. Taking place from 21-23 March 2026 i..

Visitor registration for the 23rd China International In Vitro Diagnostic Expo by CACLP is now officially open. CACLP will take place from 21–23 March 2026 at the Xiamen International Expo Center in Xiamen, Fujian Pr..

Visitor registration for the 23rd China International In Vitro Diagnostic Expo by CACLP is now officially open. CACLP will take place from 21–23 March 2026 at the Xiamen International Expo Center in Xiamen, Fujian Pr..

As part of promotional activities leading up to CACLP 2026, a series of activities took place successfully in Xiamen last week. Among them, the Xiamen Forum on Empowering the In Vitro Diagnostics Industry and Exploring New Models of Collaboration was held on 21 November 2025.

A delegation from the China Association of In Vitro Diagnostics (CAIVD), the China Professional Community of Experimental Medicine (CPCEM), and CACLP visited Incheon for a four-day industry and academic exchange progr..

On June 4 2025, Elsevier officially released the 2024 CiteScore, a key metric used to assess the impact of academic journals. VIEW, jointly sponsored by China Professional Community of Experimental Medicine (CPCEM) and published by John Wiley & Sons, achieved a CiteScore of 14.5 for 2024. This marks a continued upward trend from its 2023 score of 12.6, placing VIEW among the top journals in the fields of materials and engineering science.

Following its announcement to return to Xiamen in 2026, CACLP has received overwhelming enthusiasm from exhibitors worldwide. As of October 2025, more than 1,000 companies have confirmed their participation for next y..

On June 4 2025, Elsevier officially released the 2024 CiteScore, a key metric used to assess the impact of academic journals. VIEW, jointly sponsored by China Professional Community of Experimental Medicine (CPCEM) and published by John Wiley & Sons, achieved a CiteScore of 14.5 for 2024. This marks a continued upward trend from its 2023 score of 12.6, placing VIEW among the top journals in the fields of materials and engineering science.

From 18-22 May 2025, Brussels, Belgium, hosted the 26th IFCC-EFLM EUROMEDLAB Congress of Clinical Chemistry and Laboratory Medicine and the 49th Annual Meeting of the Royal Belgian Society of Laboratory Medicine. ..

The 22nd China International In Vitro Diagnostics Expo by CACLP and the 5th China IVD Supply Chain Expo (CISCE) took place from 22–24 March 2025 in Hangzhou, achieving unprecedented scale and impact. CACLP 2025 attra..

With just two weeks to go, anticipation is building for the 22nd China International In Vitro Diagnostic Expo by CACLP, the largest and most influential gathering of the IVD industry in China! Taking place 22-24 March..

The 7th China IVD Distribution Enterprise Forum is set to take place on 23 March 2025, at the Hangzhou Grand Convention and Exhibition Center. Under the theme "Gathering new momentum · Co-creating a ne..

As China’s in vitro diagnostic (IVD) industry continues its rapid development, numerous outstanding enterprises have made remarkable achievements in research and development, production, and market expansion. ..